BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 1082369)

  • 21. Urinary bladder carcinogenesis in the dog: preliminary studies on cellular immunity.
    Rippe DF; Ortiz-Muniz G; Block NL; Lynne CM; Shouger RB; Sigel MM
    Transplant Proc; 1975 Dec; 7(4):495-501. PubMed ID: 1105912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective cell-mediated immunity in carcinoma of the prostate.
    Thomas JW; Jerkins G; Cox C; Lieberman P
    Invest Urol; 1976 Jul; 14(1):72-5. PubMed ID: 60303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
    Braun DP; Harris JE
    J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an antitumor multipeptide complex on immunocompetent and antigen-responsive cells.
    De Barbieri A; Golferini A; Brugo A; Omesso A; Tassi GC
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):201-15. PubMed ID: 1087883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Controlled study of unspecific cellular immunity in cancer patients].
    Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
    Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein.
    Hanna N; Kalderon R; Nelken D
    Immunology; 1975 Sep; 29(3):433-43. PubMed ID: 51828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunological monitoring of patients with carcinoma of the lung. Study method and preliminary research].
    Banna P; Stivala F; Murabito R; Cordopatri F; Saggio A; Mosca F; Cinà C
    Chir Ital; 1979 Dec; 31(6):1297-1313. PubMed ID: 233422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lymphocytes. Roles in cellular immunity and humoral immunity].
    Golovtchenko AM; Raichvarg D
    Ann Biol Clin (Paris); 1975; 33(2):63-74. PubMed ID: 1080972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. II. Immunologic parameters in vitro.
    Waldman SR; Roth JA; Kern DH; Pilch YH
    J Lab Clin Med; 1975 Dec; 86(6):950-61. PubMed ID: 127818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host immunocompetence in genitourinary cancer: relation to tumor stage and prognosis.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Natl Cancer Inst Monogr; 1978 Dec; (49):105-10. PubMed ID: 311891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the immunocompetence and surface markers of lymphocytes in stored blood.
    Khan A; Wakasugi K; Hill N; Komezi T; Osamura S
    Exp Hematol; 1977 Jan; 5(1):8-12. PubMed ID: 319012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.
    Baron M; Keystone EC; Gladman DD; Lee P; Poplonski L
    Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of lymphocyte-mediated cytotoxicity after tumor resection in patients with colorectal cancer.
    Waller CA; Gill PG; MacLennan IC
    J Natl Cancer Inst; 1980 Aug; 65(2):223-30. PubMed ID: 6931244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
    Holm G; Björkholm M; Mellstedt H; Johansson B
    Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.
    Chisari FV; Routenberg JA; Edgington TS
    J Clin Invest; 1976 May; 57(5):1227-38. PubMed ID: 1083396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoprofile studies for patients with bronchogenic carcinoma. I. Correlation of pretherapy studies with survival.
    Liebler GA; Concannon JP; Magovern GJ; Dalbow MH; Hodgson SE
    J Thorac Cardiovasc Surg; 1977 Oct; 74(4):506-18. PubMed ID: 302883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.